Expert Forum
CMC: A Developmental Approach to Ensure Drug Quality – from Small-Molecule Drugs to Biotherapeutics
Your registration is successful, and you will receive an email explaining how to watch and attend the presentation.
If you know a colleague who would benefit from this presentation, use the form to invite them.
We recommend adding the event to your calendar using the button below. This includes the auditorium link, which can also be accessed before the event to submit questions for our presenters.
Presenters / Panellists
Dr. Michael Dong
Founder & Principal Consultant
MWD Consulting (USA)
Dr. Joseph Glajch
Founder & Principal Consultant
JLG AP Consulting (USA)
Further presenter/panelist to be confirmed.
Moderators
Prof. Dr. Cari Sänger-van de Griend
Expert in (bio)pharmaceutical analytical chemistry with 30 years of industrial and academic experience in method development and control strategies, including Analytical Quality by Design (AQbD), and focused on best practices and knowledge sharing.
Dr. Ewoud van Tricht
Expert in (bio)pharmaceutical analysis with over 18 years of industrial experience in analytical development, Quality Control, and Analytical Quality by Design (AQbD). He has contributed to diverse therapeutic modalities, including small molecules, viruses, and cells, at leading companies such as Janssen Vaccines and Sanofi Cell Therapy.
Brought to you by:
Ask a Question
Join the conversation (or start a discussion) on the BioQC User Community.
Contact Us
If you have any questions about the event, don’t hesitate to get in touch with the BioQC Team: Feedback & General Enquiry